Kaisa Huhtinen

13PUBLICATIONS
77CO-AUTHORS
Predictive and prognostic markersCancer diagnosisProgramming languagesCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 12, 2025
Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer.

Barun Pradhan, Jaana Oikkonen, Kaiyang Zhang

|Sep 18, 2025
CA-125 glycovariant assays enhance diagnostic sensitivity in the detection of epithelial ovarian cancer.

Stefanos Moukas, Katri Kuningas, Marjut Helle

|Aug 05, 2024
Deciphering cancer genomes with GenomeSpy: a grammar-based visualization toolkit.

Kari Lavikka, Jaana Oikkonen, Yilin Li

|Feb 22, 2023
Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes.

Sanna Pikkusaari, Manuela Tumiati, Anni Virtanen

|Apr 01, 2022
Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246-Sensitive Disease Subtype.

Anna N Cvrljevic, Umar Butt, Kaisa Huhtinen

|Feb 23, 2022
Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer.

Kaiyang Zhang, Erdogan Pekcan Erkan, Sanaz Jamalzadeh

Pageof 3

Frequent Collaborators

8 joint publications

Johanna Hynninen

5 joint publications

Sakari Hietanen

5 joint publications

Sampsa Hautaniemi

5 joint publications

Jaana Oikkonen